Multiple organ dysfunction syndrome

National Medical Journal of India

Volumn 10, Issue 6, 1997, Pages 277-282

  Wadhwa, Jyoti ^a   Sood, Rita ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; HUMAN; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BACTERIAL INFECTIONS; HUMANS; MULTIPLE ORGAN FAILURE; PROGNOSIS; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0031266939     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Baue AE. Multiple, progressive, or sequential systems failure: A syndrome of the 1970s. Arch Surg 1975;110:770-81.
2. Tilney NL, Bailey GL, Morgan AP. Sequential system failure after rupture of abdominal aortic aneurysms: An unsolved problem in postoperative care. Ann Surg 1973;178:17-22.
3. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
4. Fry DE, Pearlstein L, Fulton RL, Polk HC Jr. Multiple system organ failure: The role of uncontrolled infection. Arch Surg 1980;115:136-40.
5. Knaus WA, Wagner DP. Multiple systems organ failure: Epidemiology and prognosis. Crit Care Clin 1989;5:221-32.
6. Madoff RD, Sharpe SM, Fath JJ, Simmons RL, Cerra FB. Prolonged surgical intensive care: A useful allocation of medical resources. Arch Surg 1985;120: 698-702.
7. Marshall T, Christou NV, Meakins JL. The microbiology of multiple organ failure. Arch Surg 1988;123:309-15.
8. Polk HC Jr, Shields CL. Remote organ failure: A valid sign of occult intraabdominal infection. Surgery 1977;81:310-13.
9. Meakins JL. Etiology of multiple organ failure. J Trauma 1990;30:S165-S168.
10. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s: Systemic inflammatory response and organ dysfunction. JAMA 1994;271:226-33.
11. Cerra FB. Hypermetabolism, organ failure, and metabolic support. Surgery 1987;101:1-14.
12. Bone RC. Sir Isaac Newton, sepsis, SIRS and CARS. Crit Care Med 1996;24: 1125-8.
13. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-72.
14. Vane JR, Anggard EE, Botting RM. Regulatory function of the vascular endothelium. N Engl J Med 1990;323:27-36.
15. Cipolle MD, Pasquale MD, Cerra FB. Secondary organ dysfunction: From clinical perspectives to molecular mediators. Crit Care Clin 1993;9:261-98.
16. Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, et al. Prognostic values of tumor necrosis factor, cachectin, interleukin-1, interferon alpha and interferon gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990;161:982-7.
17. Bone RC. A personal experience with SIRS and MODS. Crit Care Med 1996;24:1417-18.
18. Rosenbloom AJ, Pinsky MR, Bryant JL, Shin A, Tran T, Whiteside T. Leucocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS: Correlation with serum interleukin-6 levels and organ dysfunction. JAMA 1995;274:58-65.
19. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV. Multiple organ failure syndrome. The gastrointestinal tract: The motor of MOF. Arch Surg 1986;121: 197-201.
20. Alexander JW, Boyce ST, Babcok GF, Gianotti L, Peck MD, Dunn DL, et al. The process of microbial translocation. Ann Surg 1990;212:496-510.
21. Cerra FB, McPherson JP, Konstantinides FN, Konstantinides NN, Teasley KM. Enterai nutrition does not prevent multiple organ failure syndrome (MOFS) after sepsis. Surgery 1988;104:727-33.
22. Cerra FB, Holman RT, Bankey PE, Mazuski JE. Nutritional pharmacology: Its role in the hypermetabolism-organ failure syndrome. Crit Care Med 1990;18:S154-8.
23. Cerra FB, Mazuski JE, Chute E, Nuwer N, Teasley KM, Lysne J, et al. Branched chain metabolic support: A prospective randomized double blind trial in surgical stress. Ann Surg 1984;199:286-91.
24. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV. Multiple organ failure syndrome: Incidence and problems of multiple organ failure syndromes. Arch Surg 1986;121:197.
25. Fleming A, Bishop M, Shoemaker W, Appel P, Sufficool W, Kuvhenguwha A, et al. Prospective trial of supranormal values as goals of resuscitation in severe trauma. Arch Surg 1992;127:1175-9.
26. Driks MR, Craven DE, Celli BR, Manning M, Burke RA, Garvin GM, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: The role of gastric colonization. N Engl J Med 1987;317:1376-82.
27. Daly JM, Lieberman MO, Goldfine J, Shou J, Weintraub F, Rosato EF, et al. Enternal nutrition with supplemental arginine, RNA and omega-3 fatty acids in patients after operation: Immunologic, metabolic, and clinical outcome. Surgery 1992;112:56-67.
28. Warren HS, Danner RL, Munford RS. Anti-endotoxin monoclonal antibodies. N Engl J Med 1992;326:1153-7.
29. McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR. Treatment of septic shock with human monoclonal antibody HA-IA - A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med 1994;121: 1-5.
30. Dhainaut JF, Vincent JL, Richard C, Lejeune P, Martin C, Fierobe L, et al. CDP571, a humanized antibody to human tumor necrosis factor-alpha: Safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CDP571 Sepsis Study Group. Crit Care Med 1995;23:1461-9.
31. Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994;271:1836-43.
32. Revhaug A, Michie H, Manson J, Watters JM, Dinarello CA, Wolff SM, et al. Inhibition of cyclo-oxygenase attenuates the metabolic response to endotoxin in humans. Arch Surg 1988;123:162-70.
33. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;217:653-8.
34. Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper KV Jr. Fibroproliferative phase of ARDS: Clinical findings and effects of corticosteroids. Chest 1991;100:943-52.
35. Schneider AJ, Voerinan HJ. Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids. Intensive Care Med 1991;17:436-7.
36. Singer M, Tighe D, Bennett ED. Pilot study of pentoxifylline in human multiple organ failure. Intensive Care Med 1990;16:A480.
37. Petros A, Bennet D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991;338:1557-8.
38. Anderson BO, Bensard DD, Harken AH. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet 1991;172:415-24.
39. Roberts DE, Dobson KE, Hall KW, Light RB. Effects of prolonged naloxone infusion in septic shock. Lancet 1988;2:699-702.
40. Olsen NC, Grizzle MK, Anderson DL. Effect of polyethylene glycol Superoxide dismutase and catalase on endotoxemia in pigs. J Appl Physiol 1987;63:1526-32.
41. Taylor FB Jr, Emerson TE Jr, Jordan R, Chang AK, Blick KE. Antithrombin III prevents the lethal effects of Eschericha coli infusion in baboons. Circ Shock 1988;26:227-35.
42. Cohen J, Aslam M, Pusey CD, Ryan CJ. Protection from endotoxemia: A rat model of plasmapheresis and specific adsorption with polymyxin B. J Infect Dis 1987;155:690-5.
43. Barzilay E, Kessler D, Berlot G, Gullo A, Geber D, Ben Zeev I. Use of extracorporeal supportive techniques as additional treatment for sepsis-induced multiple organ failure patients. Crit Care 1989;17:634-67.
44. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ system failure. Ann Surg 1985;202:685-93.
45. Raffin TA. Intensive care unit survival of patients with systemic illness. Am Rev Respir Dis 1989;140:S28-S35.
46. Barie PS, Hydo LJ, Fischer E. Comparison of APACHE II and III scoring systems for mortality prediction in critical surgical illness. Arch Surg 1995;130:77-82.
47. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52.